The market provides with a wide range of opportunities those companies that want to enhance their Consumer Health portfolio through acquisitions. Assets are currently on sale by Germany-based Merck KGaA, intending to dismiss its Consumer Health arm for €4bn, and…
Reckitt Benckiser
GlaxoSmithKline informed this morning in a short, concise press release that it will pull out of the process to acquire Pfizer’s Consumer Health division. CEO Emma Walmsley added that the group will keep reviewing other opportunities consistent with its strategy,…
The Financial Times has reported today that Britain-based GlaxoSmithKline is in pole-position to acquire Pfizer’s Consumer Health division, valued at least $20bn. Almost simultaneously Reckitt Benckiser, which last week submitted its own binding offer, has informed in a press release…
The British press likes Emma Walmsley, new GlaxoSmithKline CEO, as confirmed today by the positive article published by the British daily The Telegraph. During its first 11 months as head of the largest British pharmaceutical group, Walmsley has radically rationalized…
Bloomberg has reported today that GSK and Reckitt Benckiser have submitted a non-binding offer for Pfizer’s Consumer Health division, valued by analysts between $15bn and $20bn. Thus, GSK and RB have access to the data room and will be able…
Selling Merck KGaA’s Consumer Health unit is proving increasingly difficult as Nestlé, widely considered as the most eligible buyer, has bowed out and has renounced to the binding bid. It is not clear yet whether Nestlé’s move is due to…
Pfizer some days ago announced it hired banks to explore selling its Consumer Healthcare business or creating a spin-off. According to analysts, it is very likely that the process will result in a sale. Indeed, many groups are targeting the…
UK-based Indivior, a spin-off of Reckitt Benckiser, has lost over $1bn in capitalization as the Delaware District Court has ruled against it and in favor of India-based Dr. Reddy. Indivior had appealed against the court ruling that Dr Reddy’s generic…
Reckitt Benckiser has acquired the US-based milk formula producer Mead Johnson for $17.9bn, entering the business currently leaded by giants Nestlé and Danone, which respectively hold a 22% and a 13% market share. The agreement includes a $480m break-fee in…
UK-based consumer goods producer Reckitt Benckiser yesterday announced it has made a $16.7bn bid for Illinois, US-based baby formula maker Mead Johnson. The bid corresponds to $90 per share, that is to say a 30% premium to Mead Johnson’s closing…